The bill directs roughly $1.18 billion to preserve and expand Congressionally Directed Medical Research Programs and lock in congressional priorities for those projects, at the trade-off of higher taxpayer costs, reduced DoD budget flexibility, and some retroactive budget/accounting complications.
Researchers, hospitals, and medical research programs receive an additional ~$1.18 billion to fund Congressionally Directed Medical Research Programs, preserving and expanding research activities and grant awards.
Researchers, veterans, and ongoing Defense health projects have their work protected and aligned with congressional priorities because the Secretary of Defense is required to obligate/ expend funds to preserve program continuity and support peer‑reviewed initiatives specified in the 2024 explanatory statement.
Taxpayers face the cost of the roughly $1.18 billion increase, which could raise the deficit or crowd out other federal spending priorities.
The requirement to direct precise allocations limits the Defense Department’s flexibility to reprogram funds, potentially reducing its ability to respond to emergent military or health needs.
Defense health administrators and the Secretary of Defense must manage retroactive accounting and administrative adjustments because of the retroactive effective date, complicating budget execution.
Based on analysis of 2 sections of legislative text.
Increases FY2025 appropriations tied to Department of Defense medical research programs and requires implementation consistent with a prior explanatory statement.
Increases the FY2025 funding total tied to Congressionally Directed Medical Research Programs (CDMRP) and requires the Department of Defense to implement those funds consistent with a prior explanatory statement. The change raises the stated funding amount and makes the amendment effective retroactively as if it were included in the original FY2025 continuing appropriations law. The law directs the Secretary of Defense to obligate and spend the added funds to preserve program continuity and to follow the specific research programs, peer-reviewed initiatives, and funding allocations identified in the Consolidated Appropriations Act, 2024 explanatory statement (pages 311–314).
Official title: To amend the Full-Year Continuing Appropriations and Extensions Act, 2025 to restore amounts available for Defense Health Agency research, development, test, and evaluation, including Congressionally Directed Medical Research Programs.
Introduced June 11, 2025 by André Carson · Last progress June 11, 2025